Predictive Oncology Inc (NASDAQ:POAI) — Market Cap & Net Worth
Market Cap & Net Worth: Predictive Oncology Inc (POAI)
Predictive Oncology Inc (NASDAQ:POAI) has a market capitalization of $18.60 Million ($18.60 Million) as of June 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #25375 globally and #5304 in its home market, demonstrating a 28.64% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Predictive Oncology Inc's stock price $5.48 by its total outstanding shares 3393516 (3.39 Million). Review POAI current and long-term liabilities to assess the company's total debt and financial obligations.
Predictive Oncology Inc Market Cap History: 2015 to 2025
Predictive Oncology Inc's market capitalization history from 2015 to 2025. Data shows change from $49.88 Billion to $18.60 Million (-53.49% CAGR).
Index Memberships
Predictive Oncology Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.43 Trillion | 0.00% | #726 of 976 |
|
NASDAQ Composite
IXIC
|
$41.27 Trillion | 0.00% | #2377 of 3165 |
Weight: Predictive Oncology Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Predictive Oncology Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Predictive Oncology Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.71x
Predictive Oncology Inc's market cap is 1.71 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $49.88 Billion | $654.35K | -$4.79 Million | 76235.01x | N/A |
| 2016 | $1.90 Billion | $456.50K | -$6.53 Million | 4162.96x | N/A |
| 2017 | $685.49 Million | $654.84K | -$7.75 Million | 1046.81x | N/A |
| 2018 | $420.12 Million | $1.41 Million | -$10.09 Million | 297.61x | N/A |
| 2019 | $177.14 Million | $1.41 Million | -$19.39 Million | 125.49x | N/A |
| 2020 | $49.68 Million | $1.25 Million | -$25.88 Million | 39.67x | N/A |
| 2021 | $64.61 Million | $1.42 Million | -$19.66 Million | 45.48x | N/A |
| 2022 | $20.84 Million | $1.51 Million | -$25.74 Million | 13.84x | N/A |
| 2023 | $11.16 Million | $1.63 Million | -$13.98 Million | 6.86x | N/A |
| 2024 | $2.78 Million | $1.62 Million | -$12.20 Million | 1.71x | N/A |
Competitor Companies of POAI by Market Capitalization
Companies near Predictive Oncology Inc in the global market cap rankings as of June 17, 2026.
Key companies related to Predictive Oncology Inc by market ranking:
- Microsoft Corporation (NASDAQ:MSFT): Ranked #3 globally with a market cap of $2.93 Trillion USD.
- Oracle Corporation (NYSE:ORCL): Ranked #30 globally with a market cap of $541.65 Billion USD.
- Palantir Technologies Inc. Class A Common Stock (NYSE:PLTR): Ranked #49 globally with a market cap of $324.25 Billion USD.
- Palantir Technologies Inc. (NASDAQ:PLTR): Ranked #53 globally with a market cap of $305.95 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3 | Microsoft Corporation | NASDAQ:MSFT | $2.93 Trillion | $393.83 |
| #30 | Oracle Corporation | NYSE:ORCL | $541.65 Billion | $188.33 |
| #49 | Palantir Technologies Inc. Class A Common Stock | NYSE:PLTR | $324.25 Billion | $178.15 |
| #53 | Palantir Technologies Inc. | NASDAQ:PLTR | $305.95 Billion | $133.25 |
Predictive Oncology Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Predictive Oncology Inc's market cap moved from $49.88 Billion to $ 18.60 Million, with a yearly change of -53.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $18.60 Million | +568.29% |
| 2024 | $2.78 Million | -75.08% |
| 2023 | $11.16 Million | -46.42% |
| 2022 | $20.84 Million | -67.75% |
| 2021 | $64.61 Million | +30.05% |
| 2020 | $49.68 Million | -71.95% |
| 2019 | $177.14 Million | -57.84% |
| 2018 | $420.12 Million | -38.71% |
| 2017 | $685.49 Million | -63.93% |
| 2016 | $1.90 Billion | -96.19% |
| 2015 | $49.88 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Predictive Oncology Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.60 Million USD |
| MoneyControl | $18.60 Million USD |
| MarketWatch | $18.60 Million USD |
| marketcap.company | $18.60 Million USD |
| Reuters | $18.60 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Predictive Oncology Inc
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D cult… Read more